Search

everythinglearnresearchcommunity

for

Search:↓

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Rasayana therapy can enhance female reproductive health at different life stages.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

PCOS affects women's hormones and metabolism, but can be managed with lifestyle changes and treatments.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Multiple treatments work best for hair loss.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Innovative methods are reducing animal testing and improving biomedical research.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Reversing female hair loss.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.